Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma

✍ Scribed by Lucie M. Heinzerling; Margarete Urbanek; Jens O. Funk; Stefan Peker; Oliver Bleck; Karsten Neuber; Günter Burg; Peter von den Driesch; Reinhard Dummer

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 687 KB
• Volume: 89
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/1097-0142(20001015)89:8<1835::aid-cncr26>3.0.co;2-h